Cyclophosphamide + FLUDARABINE + Prulacabtagene Leucel

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Cyclophosphamide + FLUDARABINE + Prulacabtagene Leucel
Treatment and conditionWhere it standsTrials
Cyclophosphamide + FLUDARABINE + Prulacabtagene Leucel for scleroderma, systemicPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1